From: Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
Concentration of Angelica Sinensis treatment (ng/mL) | ||||||||
---|---|---|---|---|---|---|---|---|
Control | 1 | 10 | 102 | 103 | 104 | 105 | 106 | |
24 h | 100.00 ± 3.53 | 99.45 ± 4.09 | 99.89 ± 5.64 | 98.18 ± 4.52 | 93.94 ± 6.59 | 91.24 ± 4.34 | 83.62 ± 5.07* | 74.41 ± 5.88* |
48 h | 100.00 ± 3.42 | 100.15 ± 5.34 | 100.04 ± 5.56 | 100.13 ± 5.75 | 93.49 ± 4.44 | 91.22 ± 4.09 | 75.08 ± 5.15* | 68.82 ± 4.65* |
72 h | 100.00 ± 3.75 | 98.56 ± 3.49 | 99.42 ± 5.21 | 99.17 ± 4.86 | 91.31 ± 3.92 | 90.64 ± 3.59 | 74.93 ± 5.26* | 68.45 ± 4.53* |